comparemela.com
Home
Live Updates
Almirall obtains approval from EC for atopic dermatitis ther
Almirall obtains approval from EC for atopic dermatitis ther
Almirall obtains approval from EC for atopic dermatitis therapy
Almirall has obtained approval from EC for EBGLYSS (lebrikizumab) to treat adult and adolescent patients with moderate-to-severe atopic dermatitis (AD).
Related Keywords
Switzerland ,
United Kingdom ,
Germany ,
Eli Lilly ,
Volker Koscielny ,
,